0001209191-21-027585.txt : 20210420
0001209191-21-027585.hdr.sgml : 20210420
20210420172853
ACCESSION NUMBER: 0001209191-21-027585
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210420
FILED AS OF DATE: 20210420
DATE AS OF CHANGE: 20210420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kuhn Rebecca
CENTRAL INDEX KEY: 0001855659
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40337
FILM NUMBER: 21838861
MAIL ADDRESS:
STREET 1: C/O NEUROPACE INC
STREET 2: 455 N. BERNARDO AVENUE
CITY: MOUTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroPace Inc
CENTRAL INDEX KEY: 0001528287
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 223550230
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 455 N. BERNARDO AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 6502372700
MAIL ADDRESS:
STREET 1: 455 N. BERNARDO AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-04-20
0
0001528287
NeuroPace Inc
NPCE
0001855659
Kuhn Rebecca
455 N. BERNARDO AVENUE
MOUNTAIN VIEW
CA
94043
0
1
0
0
Chief Financial Officer
Common Stock
3226
D
Stock Option (Right to Buy)
0.03
2030-10-29
Common Stock
196153
D
Stock Option (Right to Buy)
0.03
2020-11-12
Common Stock
10634
D
Stock Option (Right to Buy)
0.03
2022-11-12
Common Stock
692
D
Stock Option (Right to Buy)
0.03
2025-02-05
Common Stock
482
D
Stock Option (Right to Buy)
0.03
2024-02-10
Common Stock
254
D
1/48th of the shares subject to the option vest in equal monthly installments commencing September 19, 2020.
25% of the shares subject to the option vest on Janaury 1, 2018; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.
The share underlying the option are fully vested.
1/48th of the shares subject to the option vest in equal monthly installments commencing December 11, 2014.
1/48th of the shares subject to the option vest in equal monthly installments commencing September 23, 2014.
/s/ Mark B. Weeks, Attorney-in-Fact
2021-04-20
EX-24.3_980095
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned
hereby constitutes and appoints Michael Favet of NeuroPace, Inc.
and Mark Weeks, Seth Gottlieb, Ryan James,
Felipe Campos Lara Pereira, Kris Peardon,
Debbie Wilkins, and Emma Levine Sporer of
Cooley LLP, or any of them signing singly,
with full power of substitution, the
undersigned true and lawful attorney in fact to:
(1)execute for and on behalf of the undersigned, in
the undersigned capacity as an officer,
director or beneficial owner of more than 10%
of a registered class of securities of NeuroPace, Inc. (the "Company"),
Forms 3, 4 and 5 (including any amendments thereto)
in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act")
and the rules thereunder and a Form ID, Uniform Application for Access Codes to
File on EDGAR;
(2)do and perform any and all acts for and
on behalf of the undersigned that may be
necessary or desirable to execute such
Forms 3, 4 or 5 or Form ID
(including any amendments thereto)
and timely file such forms
with the United States
Securities and Exchange Commission and any stock exchange or similar authority;
and
(3)take any other action of any nature
whatsoever in connection with the
foregoing which, in the
opinion of such attorney-in-fact,
may be of benefit, in the best interest of,
or legally required by, the undersigned,
it being understood that the
documents executed by such attorney-in-fact
on behalf of the undersigned pursuant
to this Power of Attorney shall
be in such form and shall contain
such terms and conditions as such
attorney-in-fact may approve in such
attorney-in-facts discretion.
The undersigned hereby grants to each
such attorney-in-fact full power and authority
to do and perform any and every
act and thing whatsoever requisite,
necessary or proper to be done in the
exercise of any of the rights and
powers herein granted, as fully to
all intents and purposes as the
undersigned might or could do if personally
present, with full power of substitution or
revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such
attorney-in-facts
substitute or substitutes, shall lawfully do
or cause to be done by virtue of this power of
attorney and the rights and powers
herein granted.
The undersigned acknowledges that the
foregoing attorneys-in-fact,
in serving in such capacity at the request of
the undersigned, are not assuming, nor is the
Company assuming, any of the
undersigned responsibilities to
comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in
full force and effect until the
earliest to occur of (a) the undersigned
is no longer required to file Forms 3, 4 and 5
with respect to the undersigned holdings
of and transactions in securities
issued by the Company, (b) revocation by the
undersigned in a signed writing delivered to the foregoing
attorneys-in-fact or (c) as to any attorney-in-fact
individually,until such attorney-in-fact is no longer
employed by the Company or Cooley LLP.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 31st day of March, 2021.
/s/ Rebecca Kuhn
Rebecca Kuhn